secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001493152-25-003631
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed receives Nasdaq minimum bid price deficiency notice; sells Series C preferred shares
--------------------------------------------------------------------------------

- Nasdaq notice on Jan 23: common stock closing bid below $1 for 30 consecutive days; 180-day cure period until July 22, 2025.
- To regain compliance, closing bid must be at least $1 for 10 consecutive business days.
- On Jan 24, sold 2,653 Series C Convertible Preferred shares for ~$2.653M via cancellation of unsecured debt.
- Conversion at voluntary price $1.068/share would issue ~2.48M common shares; at floor $0.2136, ~12.42M shares.
- Company intends to consider all available options to regain compliance with Nasdaq listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225003631/0001493152-25-003631-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225003631/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003631

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer